143 related articles for article (PubMed ID: 33568899)
1. Use of Adjuvant Endocrine Therapy Among Post-Menopausal Breast Cancer Patients in Malaysia.
Saiful Bahri A; Tuan Mahmood TM; Abdul-Aziz SA; Makmor-Bakry M; Mohamed Shah N
Patient Prefer Adherence; 2021; 15():227-235. PubMed ID: 33568899
[TBL] [Abstract][Full Text] [Related]
2. Adherence to adjuvant endocrine therapy for breast cancer: a qualitative exploration of attribution of symptoms among post-menopausal women.
Lee AY; Lyons AT; Makris V; Kamaraju S; Stolley MR; Neuner JM; Flynn KE
Support Care Cancer; 2024 Apr; 32(4):265. PubMed ID: 38565669
[TBL] [Abstract][Full Text] [Related]
3. Women with breast cancer's perceptions of nurse-led telephone-based motivational interviewing consultations to enhance adherence to adjuvant endocrine therapy: a qualitative study.
Gagné M; Lauzier S; Lemay M; Loiselle CG; Provencher L; Simard C; Guillaumie L
Support Care Cancer; 2022 Jun; 30(6):4759-4768. PubMed ID: 35133477
[TBL] [Abstract][Full Text] [Related]
4. The Patient's Voice: Adherence, Symptoms, and Distress Related to Adjuvant Endocrine Therapy After Breast Cancer.
Jacobs JM; Walsh EA; Park ER; Berger J; Peppercorn J; Partridge A; Horick N; Safren SA; Temel JS; Greer JA
Int J Behav Med; 2020 Dec; 27(6):687-697. PubMed ID: 32495240
[TBL] [Abstract][Full Text] [Related]
5. Optimization of an Information Leaflet to Influence Medication Beliefs in Women With Breast Cancer: A Randomized Factorial Experiment.
Green SMC; Hall LH; French DP; Rousseau N; Parbutt C; Walwyn R; Smith SG
Ann Behav Med; 2023 Oct; 57(11):988-1000. PubMed ID: 37494669
[TBL] [Abstract][Full Text] [Related]
6. Deconstructing Decisions to Initiate, Maintain, or Discontinue Adjuvant Endocrine Therapy in Breast Cancer Survivors: A Mixed-Methods Study.
Bluethmann SM; Murphy CC; Tiro JA; Mollica MA; Vernon SW; Bartholomew LK
Oncol Nurs Forum; 2017 May; 44(3):E101-E110. PubMed ID: 28635973
[TBL] [Abstract][Full Text] [Related]
7. Exploring the role of physician communication about adjuvant endocrine therapy among breast cancer patients on active treatment: a qualitative analysis.
Farias AJ; Ornelas IJ; Hohl SD; Zeliadt SB; Hansen RN; Li CI; Thompson B
Support Care Cancer; 2017 Jan; 25(1):75-83. PubMed ID: 27557832
[TBL] [Abstract][Full Text] [Related]
8. Women's Beliefs on Early Adherence to Adjuvant Endocrine Therapy for Breast Cancer: A Theory-Based Qualitative Study to Guide the Development of Community Pharmacist Interventions.
Humphries B; Collins S; Guillaumie L; Lemieux J; Dionne A; Provencher L; Moisan J; Lauzier S
Pharmacy (Basel); 2018 Jun; 6(2):. PubMed ID: 29890738
[TBL] [Abstract][Full Text] [Related]
9. Exploring the role of social support and adjuvant endocrine therapy use among breast cancer survivors.
Toledo G; Ochoa CY; Farias AJ
Support Care Cancer; 2020 Jan; 28(1):271-278. PubMed ID: 31037379
[TBL] [Abstract][Full Text] [Related]
10. Health belief about adjuvant endocrine therapy in premenopausal breast cancer survivors: a qualitative study.
Xu L; Wang A
Patient Prefer Adherence; 2019; 13():1519-1525. PubMed ID: 31564839
[TBL] [Abstract][Full Text] [Related]
11. Understanding pain related to adjuvant endocrine therapy after breast cancer: A qualitative report.
Walsh EA; Chabria R; Vranceanu AM; Park ER; Post K; Peppercorn J; Temel JS; Greer JA; Jacobs JM
Eur J Cancer Care (Engl); 2022 Nov; 31(6):e13723. PubMed ID: 36196499
[TBL] [Abstract][Full Text] [Related]
12. Modifiable risk factors for adherence to adjuvant endocrine therapy among breast cancer patients.
Jacob Arriola KR; Mason TA; Bannon KA; Holmes C; Powell CL; Horne K; O'Regan R
Patient Educ Couns; 2014 Apr; 95(1):98-103. PubMed ID: 24492157
[TBL] [Abstract][Full Text] [Related]
13. Understanding adjuvant endocrine therapy persistence in breast Cancer survivors.
Lambert LK; Balneaves LG; Howard AF; Chia SK; Gotay CC
BMC Cancer; 2018 Jul; 18(1):732. PubMed ID: 29996816
[TBL] [Abstract][Full Text] [Related]
14. Both "Vitamin L for Life" and "One Milligram of Satan": A Multi-Perspective Qualitative Exploration of Adjuvant Endocrine Therapy Use after Breast Cancer.
Toivonen KI; Oberoi D; King-Shier K; Piedalue KL; Rash JA; Carlson LE; Campbell TS
Curr Oncol; 2021 Jul; 28(4):2496-2515. PubMed ID: 34287250
[TBL] [Abstract][Full Text] [Related]
15. The lived experience of breast cancer patients on adjuvant endocrine therapy: Side effects and coping strategies during the first year of medication initiation.
Gomaa S; Lopez A; Slamon R; Smith R; Telushi E; Lapitan E; Nightingale G; Miller S; Wen KY
Res Sq; 2023 Jan; ():. PubMed ID: 36778385
[TBL] [Abstract][Full Text] [Related]
16. Psychometric properties of the Beliefs about Medicine Questionnaire-adjuvant endocrine therapy (BMQ-AET) for women taking AETs following early-stage breast cancer.
Brett J; Hulbert-Williams NJ; Fenlon D; Boulton M; Walter FM; Donnelly P; Lavery B; Morgan A; Morris C; Horne R; Watson E
Health Psychol Open; 2017; 4(2):2055102917740469. PubMed ID: 29379627
[TBL] [Abstract][Full Text] [Related]
17. Patient experiences and views on pharmaceutical care during adjuvant endocrine therapy for breast cancer: A qualitative study.
En-Nasery-de Heer S; Tromp VNMF; Westerman MJ; Konings I; Beckeringh JJ; Boons CLM; Timmers L; Hugtenburg JG
Eur J Cancer Care (Engl); 2022 Nov; 31(6):e13749. PubMed ID: 36300863
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant endocrine therapy after breast cancer: a qualitative study of factors associated with adherence.
Brett J; Boulton M; Fenlon D; Hulbert-Williams NJ; Walter FM; Donnelly P; Lavery BA; Morgan A; Morris C; Watson EK
Patient Prefer Adherence; 2018; 12():291-300. PubMed ID: 29497284
[TBL] [Abstract][Full Text] [Related]
19. Healthcare Provider Perspectives on Adherence to Adjuvant Endocrine Therapy after Breast Cancer.
Lambert LK; Balneaves LG; Howard AF; Chia SLK; Gotay CC
Curr Oncol; 2021 Apr; 28(2):1472-1482. PubMed ID: 33918560
[TBL] [Abstract][Full Text] [Related]
20. Perspectives of postmenopausal breast cancer survivors on adjuvant endocrine therapy-related symptoms.
van Londen GJ; Donovan HS; Beckjord EB; Cardy AL; Bovbjerg DH; Davidson NE; Morse JQ; Switzer GE; Verdonck-de Leeuw IM; Dew MA
Oncol Nurs Forum; 2014 Nov; 41(6):660-8. PubMed ID: 25355021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
